Vatelizumab

From Wikipedia, the free encyclopedia
Vatelizumab ?
Monoclonal antibody
Type Whole antibody
Source Humanized
Target integrin alpha 2
Clinical data
Legal status ?
Identifiers
CAS number 1238217-55-4 N
ATC code None
Chemical data
Formula ?
 N (what is this?)  (verify)

Vatelizumab is an immunomodulator. It binds to integrin alpha 2.[1]

References

  1. ↑ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 105" (PDF). WHO Drug Information 25 (2). 
Monoclonal antibodies for the immune system
Immune system ("-l(i[m])-")
Human ("-limu-")
Mouse ("-limo-")
Chimeric ("-lixi-")
Humanized ("-lizu-")
Chimeric + humanized
("-lixizu-")
Interleukin ("-k(i[n])-")
Human ("-kinu-")
Humanized ("-kizu-", "-kinzu-")
Inflammatory lesions ("-les-")
Mouse ("-leso-")

M: LMC

cell/phys/auag/auab/comp, igrc

imdf/ipig/hyps/tumr

proc, drug (L3/4)


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.